SCHOTT Poonawalla starts work on $400 million India IPO
In short
SCHOTT Poonawalla has started work on a $400 million IPO in India. The company is backed by Germany’s SCHOTT Pharma and TPG Growth, and Serum Institute of India holds a minority stake.
This matters because it points to a new public-market listing in India. The reporting does not say when the IPO will launch or what price it will seek.
What the reporting says
SCHOTT Poonawalla, backed by Germany’s SCHOTT Pharma and TPG Growth, has begun work on a $400 million India IPO. The publisher summary added that billionaire Adar Poonawalla-led Serum Institute of India also holds a minority stake in the firm. The immediate consequence is an early step toward a listed offering, while the timing, valuation details and filing status were not stated.
Why it matters
SCHOTT Poonawalla has begun work on a $400 million India IPO, with backing from Germany’s SCHOTT Pharma and TPG Growth. The publisher summary also says Serum Institute of India, led by Adar Poonawalla, holds a minority stake. The reporting indicates an IPO process is underway, but it does not give filing timing, valuation or listing dates.